Blepharitis

Definition | Aetiology | Pathophysiology | Risk Factors | Signs and Symptoms | Investigations | Management

Definition

Blepharitis is a chronic inflammatory condition affecting the eyelid margins, leading to irritation, redness, and crusting. It is often associated with meibomian gland dysfunction or bacterial colonisation.

Aetiology

  • Anterior blepharitis: associated with bacterial infection (Staphylococcus aureus) or seborrhoeic dermatitis.
  • Posterior blepharitis: due to meibomian gland dysfunction, leading to altered tear film composition.
  • Mixed blepharitis: combination of anterior and posterior blepharitis.

Pathophysiology

  • Inflammation of the eyelid margins disrupts the normal tear film.
  • Chronic irritation and bacterial overgrowth lead to crusting and eyelid redness.
  • Meibomian gland dysfunction contributes to evaporative dry eye.

Risk Factors

  • History of seborrhoeic dermatitis, rosacea, or acne.
  • Contact lens wear.
  • Ocular surface disorders (dry eye disease).
  • Poor eyelid hygiene.

Signs and Symptoms

  • Eyelid redness, irritation, and crusting at the base of eyelashes.
  • Burning or gritty sensation in the eyes.
  • Watery or dry eyes.
  • Intermittent blurry vision.
  • Occasional eyelash loss or misdirection.

Investigations

  • Slit-lamp examination: assesses eyelid margins, meibomian gland function, and tear film quality.
  • Swab for culture: if infection is suspected and resistant to standard treatment.

Management

1. Conservative Management:

  • Warm compresses to soften eyelid debris and improve meibomian gland function.
  • Eyelid hygiene with diluted baby shampoo or commercial lid wipes.
  • Artificial tears for associated dry eye symptoms.

2. Medical Management:

  • Topical antibiotics (e.g., chloramphenicol ointment) if bacterial involvement suspected.
  • Oral tetracyclines (e.g., doxycycline) for persistent posterior blepharitis.
  • Short term topical steroids in severe inflammatory cases (under specialist supervision).

3. Referral:

  • Ophthalmology: if symptoms persist despite treatment or if significant meibomian gland dysfunction is present.
  • Dermatology: if underlying seborrhoeic dermatitis or rosacea requires management.